GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Plasmapp Co Ltd (XKRX:405000) » Definitions » Altman Z-Score

Plasmapp Co (XKRX:405000) Altman Z-Score : -1.03 (As of May. 29, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Plasmapp Co Altman Z-Score?

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Warning Sign:

Altman Z-score of -1.08 is in distress zone. This implies bankruptcy possibility in the next two years.

Plasmapp Co has a Altman Z-Score of -1.03, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for Plasmapp Co's Altman Z-Score or its related term are showing as below:

XKRX:405000' s Altman Z-Score Range Over the Past 10 Years
Min: -1.08   Med: 0.13   Max: 0.69
Current: -1.08

During the past 4 years, Plasmapp Co's highest Altman Z-Score was 0.69. The lowest was -1.08. And the median was 0.13.


Plasmapp Co Altman Z-Score Historical Data

The historical data trend for Plasmapp Co's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Plasmapp Co Altman Z-Score Chart

Plasmapp Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Altman Z-Score
- - 0.69 -0.54

Plasmapp Co Quarterly Data
Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Altman Z-Score Get a 7-Day Free Trial Premium Member Only 0.35 0.21 0.04 -0.54 -1.00

Competitive Comparison of Plasmapp Co's Altman Z-Score

For the Medical Devices subindustry, Plasmapp Co's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Plasmapp Co's Altman Z-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Plasmapp Co's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where Plasmapp Co's Altman Z-Score falls into.



Plasmapp Co Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Plasmapp Co's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*0.1225+1.4*-0.9589+3.3*-0.3366+0.6*1.4909+1.0*0.3792
=-1.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Mar. 2024:
Total Assets was ₩40,320 Mil.
Total Current Assets was ₩24,092 Mil.
Total Current Liabilities was ₩19,154 Mil.
Retained Earnings was ₩-38,665 Mil.
Pre-Tax Income was -3593.179 + -4613.08 + -3379.815 + -4254.977 = ₩-15,841 Mil.
Interest Expense was -650.335 + -565.135 + -676.835 + -377.714 = ₩-2,270 Mil.
Revenue was 4076.708 + 3979.909 + 4532.189 + 2699.866 = ₩15,289 Mil.
Market Cap (Today) was ₩53,116 Mil.
Total Liabilities was ₩35,627 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(24091.548 - 19154.04)/40320.053
=0.1225

X2=Retained Earnings/Total Assets
=-38664.736/40320.053
=-0.9589

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-15841.051 - -2270.019)/40320.053
=-0.3366

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=53116.001/35626.876
=1.4909

X5=Revenue/Total Assets
=15288.672/40320.053
=0.3792

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

Plasmapp Co has a Altman Z-Score of -1.03 indicating it is in Distress Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.


Plasmapp Co  (XKRX:405000) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


Plasmapp Co Altman Z-Score Related Terms

Thank you for viewing the detailed overview of Plasmapp Co's Altman Z-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Plasmapp Co (XKRX:405000) Business Description

Traded in Other Exchanges
N/A
Address
Room 111, Bio Venture Center-dong, 125 Gwahak-ro, Yuseong-gu,, Daejeon, KOR
Plasmapp Co Ltd operates as a medical solution company. It develops sterilization and disinfection technologies, regeneration activation technologies, and other technologies. Based on this technology, Plasmapp has devised a novel plasma sterilizer for medical tools known as STERPACK packaging pouches.

Plasmapp Co (XKRX:405000) Headlines

No Headlines